Remanded (sent back)
The Board remands the matter for a new examination to properly evaluate the severity of the Veteran's rheumatoid arthritis, discounting the ameliorative effects of medication.
The deciding factor: The February 2020 and April 2023 VA examinations did not appropriately discount the ameliorative effects of the Veteran's medications, necessitating a new examination to accurately assess the severity of his condition.
- Claimed conditions
- rheumatoid arthritis
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- October 6, 2025
- Citation
- A25086087
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.